Yemin Ezra Uzi

Director Yemin Ezra Uzi sells 34,026 shares of Delek US Holdings; appears to be part of a recent liquidation sequence.

Director Yemin Ezra Uzi has executed his eighth consecutive sale of Delek US Holdings stock, continuing a selling pattern that accelerated over the preceding days. This latest transaction reduces his holdings by over seven percent and occurs while the stock trades well below its recent highs, despite having recovered substantially from its lows. Notably, the company is unprofitable and burning cash operationally, even as revenues have grown sharply—a combination that typically raises scrutiny around large insider liquidations. The rapid-fire nature of these sales (with prior transactions just three and five trading days earlier) suggests systematic position reduction rather than opportunistic trading around specific catalysts. For investors holding Delek, the key question is whether this represents mere portfolio rebalancing or reflects director-level concern about near-term company prospects—and the historical context here is limited, as recent prior sales are too fresh to evaluate their outcomes.

Director Yemin Ezra Uzi sells $4.9M in DK stock across multiple tranches while company grapples with losses.

Director Yemin Ezra Uzi executed a large, structured liquidation of nearly $4.9 million in Delek US Holdings stock over two trading days, disposing of approximately 100,000 shares across eight separate tranches. The timing is noteworthy: the stock is trading near its 52-week high after recovering sharply from deeply depressed levels, creating an attractive exit window for an insider. However, this sale occurs against a troubling financial backdrop—the company is unprofitable with large quarterly losses and deteriorating earnings, suggesting the director may be taking advantage of a near-peak valuation to reduce exposure. The structured, multi-tranche nature of the sale (rather than a single block order) is consistent with Rule 10b5-1 plan execution, indicating this was pre-planned rather than reactive, but the scale and timing together signal cautious sentiment rather than confidence in the company's near-term direction.

Director Yemin Ezra Uzi sells 55,356 shares (8.9% of holdings) for $2,428,475.70 in 4 transactions at DK

Yemin Ezra Uzi, a director at Delek US Holdings, executed 4 separate sales totaling 55,356 shares for $2,428,475.70 on 2026-03-18 at an blended average price of $43.87, reducing his position from 625,007 to 569,651 shares. His prior 3 measurable sales at DK were well-timed at the 90-day mark (30d -15.5%, 90d -21.2% on 2025-11-07; 30d +2.3%, 90d -25.8% on 2025-10-27), establishing a 100.00% well-timed rate on same-ticker history, though the cross-ticker track record shows 10 prior sells with an average 90-day return of -24.9% and a 100.00% well-timed rate. The current stock price of $44.24 is -2.6% from the 52-week high of $45.41, and the 30-day and 90-day momentum (+27.8% and +44.2% respectively) suggest the stock has been in an uptrend. Fundamental headwinds are material: the company reported -9.5% annual revenue growth, full-year net income was negative (though the latest quarter showed $178.0M in net income), and the P/E ratio of 116.42 is elevated relative to peers. The sale occurs in the context of strong recent price momentum and weak full-year profitability.

Director Yemin Ezra Uzi sold 84,650 shares (84.6K) at $43.17 for $3,654,340.50 ($3.7M); 5 of 5 prior same-ticker sells were well-timed.

Yemin Ezra Uzi, a Director at Delek US Holdings, executed 2 separate sales totaling 84,650 shares at $43.17 on 2026-03-04, reducing holdings from 697,795 to 613,145 shares (-12.1%). This sale is material in size and in timing context: his prior 5 trades at DK were all sales, and all 5 were well-timed at the 90-day mark, with outcomes ranging from -15.5% to -26.6%. The current stock is trading at $42.29, only -5.6% from its 52-week high, and has rallied +29.3% in 30 days. The company's fundamentals are mixed: profitability is strained (negative full-year net income, -9.5% revenue growth, elevated P/E of 111.29), which aligns with the pattern of his prior sales preceding declines. His cross-ticker sell history shows a 100% well-timed rate (8 prior sales), though with higher volatility in timing outcomes. The repetition of well-timed exit patterns at this specific ticker suggests consistent signal awareness of deteriorating valuations or operational headwinds.

Director Yemin Ezra Uzi sold 55,350 shares at $43.09 in 2 transactions for $2.4M on 2025-11-07

Director Yemin Ezra Uzi executed two separate sales totaling 55,350 shares for $2,385,031.50 at a blended average price of $43.09, reducing his holdings by 7.5% to 679,656 shares post-transaction. The transaction price of $43.09 represents approximately a 5.5% premium to the current price of $40.85, suggesting the sales occurred during a recent rally in the stock (which has gained 19.8% over the past 30 days and 94.4% over the past 90 days from a 52-week low of $11.55). Notably, this sale follows a pattern: the insider has executed 5 prior trades at DK within the last two weeks (three on 2025-10-23 and 2025-10-24, two on 2025-10-27), all sells. His cross-ticker track record shows a 71.43% win rate on buys but his recent activity at this ticker has consisted exclusively of sales, which merits attention given the company's deteriorating fundamentals: annual revenue contracted 29.9% year-over-year and the company was unprofitable over its most recent full fiscal year despite current quarterly revenue of $2.9B.

Director Yemin Ezra Uzi sold 132,612 shares of DK for $5,056,283.28 across 6 transactions at $38.01–$38.16, reducing holdings 15.4%

Yemin Ezra Uzi, a director, executed 6 separate sales totaling 132,612 shares for $5,056,283.28 between October 23–27, 2025, at prices ranging from $38.01 to $38.16 (blended average $38.13). This sale reduced his holdings from 861.6K shares to 729.0K shares, a -15.4% reduction in his position. The timing is noteworthy: the stock is currently at $37.85, near its 52-week high, and has appreciated +15.4% over the prior 30 days and +61.3% over 90 days. Against this backdrop of recent strength, the director's significant reduction in ownership stake merits investor attention, particularly given that Delek US Holdings is currently unprofitable (net income of -$106.4M in the latest quarter) and revenue has declined -29.9% year-over-year, creating a tension between price momentum and underlying fundamentals.

Delek US Chairman Yemin Ezra Uzi bought 4,875 shares at $15.40 on 2025-03-14; stock down -52.0% from 52-week high.

Yemin Ezra Uzi, as Chairman, purchased 4,875 shares at $15.40, adding 0.6% to his holdings of 833.1K shares post-transaction. The purchase occurs in a cluster context: 3 other insiders also bought within the past 14 days, suggesting coordinated management engagement at depressed valuations. However, the company's fundamentals are strained—net income was $-76.8M over its latest full fiscal year, annual revenue declined -29.9%, and the stock has fallen -52.0% from its 52-week high and -12.3% over the past 30 days. At the same ticker, his prior two measurable buys (2024-11-18 and 2024-12-16) yielded 90-day returns of -3.8% and -5.0% respectively, establishing a pattern of purchases that did not arrest subsequent declines. The timing and cluster pattern warrant attention given the company's operating losses and revenue contraction, though the modest share count increase (0.6%) limits the signal strength.

Chairman Ezra Uzi bought 5,240 shares of DK at $14.52 on 2025-03-13; stock now -53.1% from 52-week high amid cluster buy pattern

Chairman Yemin Ezra Uzi purchased 5,240 shares at $14.52, increasing holdings to 828,270 shares (+0.6%). The buy occurred in a cluster pattern with 3 other insiders purchasing within 14 days, suggesting coordinated confidence during a steep drawdown. However, the company fundamentals are stressed: annual revenue declined -29.9% and net income was $-76.8M in the latest quarter, with the company unprofitable over its most recent full fiscal year. The stock is -53.1% from its 52-week high and -12.2% over the past 30 days. Of Uzi's 4 prior trades at DK, only 1 of them showed a positive 90-day outcome, indicating a weak timing pattern at this ticker specifically.

DK chairman bought 5,085 shares at $14.50 on 2025-03-12; stock down -56.2% from 52-week high, 3 insiders bought within 14 days.

Chairman Yemin Ezra Uzi purchased 5,085 shares at $14.50, a modest 0.6% increase to his 823.0K share position, as Delek US Holdings trades 56.2% below its 52-week peak and has fallen 25.1% over the past 30 days. The company reported a $-76.8M net loss on $3.0B quarterly revenue with -29.9% annual revenue decline, indicating material operational pressure. A cluster pattern emerged with 3 other insiders buying within the same 14-day window, though his cross-ticker buy track record shows only 50% accuracy over the 90-day horizon (5 prior buys, 50.00% win rate). At this specific ticker, his prior 3 DK trades have shown mixed results: a -3.8% 90-day loss on the November 2024 purchase and a +23.1% 30-day gain on the December 2024 purchase, with neither establishing a consistent timing pattern. The stock's sharp decline and unprofitability warrant scrutiny of whether this accumulation reflects a contrarian assessment or signals deeper concern among the insider group.

DKL Chairman Yemin Ezra Uzi buys 3,750 shares at $39.95; stock -16.2% from 52-week high amid -1.5% annual revenue decline

Yemin Ezra Uzi, Chairman of Delek Logistics Partners, LP, purchased 3,750 shares at $39.95 on 2024-12-16, increasing his holdings by 2.4% to 162.2K shares. The transaction occurs with the stock trading 16.2% below its 52-week high and the company reporting annual revenue contraction of -1.5%, despite stable profitability metrics (P/E 15.85, $32.6M net income on $214.1M revenue). His prior buy at this ticker on 2024-11-14 generated a 30-day return of +3.0%, while his broader open-market track record across all tickers shows 3 prior buys with an average 30-day return of -4.2%, indicating inconsistent timing outcomes. The purchase is modest relative to his existing position, and absent disclosed forward-looking commentary, the transaction reflects a Chairman's continued incremental equity accumulation at prevailing market prices during a period of depressed valuation relative to recent trading range.